Latest Commercial Scale Up News

Page 8 of 20
Telix Pharmaceuticals reports a robust 53% revenue jump in Q3 2025 and raises its full-year guidance, underpinned by key reimbursement wins and expanding clinical programs.
Ada Torres
Ada Torres
14 Oct 2025
Zeotech Limited has signed a non-binding MOU with Cement Australia to collaborate on advancing AusPozz™, a high-reactivity metakaolin product aimed at reducing carbon emissions in concrete production.
Maxwell Dee
Maxwell Dee
14 Oct 2025
Latrobe Magnesium Limited (ASX – LMG) has launched an $8 million equity raising to fund the ramp-up of its magnesium metal production and advance feasibility studies for a larger commercial plant. The company’s patented hydromet process converts brown coal ash into sustainable magnesium with significantly lower emissions than global peers.
Maxwell Dee
Maxwell Dee
13 Oct 2025
Latrobe Magnesium has locked in $10 million through a placement and entitlement offer to complete its demonstration plant and push towards commercial-scale magnesium production.
Maxwell Dee
Maxwell Dee
13 Oct 2025
Volt Resources is advancing its Alabama Graphite Refinery project to produce high purity graphite in the US, leveraging proven Ukrainian technology and targeting near-term commercial production with low capital costs and strong environmental credentials.
Maxwell Dee
Maxwell Dee
7 Oct 2025
Latrobe Magnesium Limited has successfully commenced production of Magnesium Oxide at its Hazelwood North Demonstration Plant, marking a significant operational milestone. The company is advancing towards steady-state output and exploring by-product commercialisation.
Maxwell Dee
Maxwell Dee
25 Sept 2025
Strategic Elements Ltd has successfully fabricated over 2,000 Energy Ink™ prototype cells in a commercial setting, marking a pivotal step toward global collaboration and product development. This breakthrough validates the reproducibility of their moisture-powered printable ink technology at scale.
Sophie Babbage
Sophie Babbage
25 Sept 2025
Clover Corp has reported a standout FY25 with robust revenue and profit growth, driven by new product launches and strategic investments that strengthen its global supply chain and market reach.
Victor Sage
Victor Sage
23 Sept 2025
EVE Health Group has begun distributing Dyspro™, a novel cannabinoid-based treatment for dysmenorrhoea and endometriosis, through a national telehealth partnership. This launch targets a significant unmet need in women’s health with a growing global market.
Ada Torres
Ada Torres
22 Sept 2025
Meteoric Resources has confirmed exceptional rare earth recoveries from continuous piloting at ANSTO, producing high-quality Mixed Rare Earth Carbonate and demonstrating effective waste handling. This milestone advances the Caldeira Project towards commercial development and offtake agreements.
Maxwell Dee
Maxwell Dee
18 Sept 2025
Iondrive Limited has inked a binding Term Sheet with Livium Limited to commercialise its innovative Deep Eutectic Solvent (DES) technology for recycling critical materials from batteries, solar panels, and e-waste in Australia, with a pilot plant set to begin commissioning by the end of 2025.
Maxwell Dee
Maxwell Dee
17 Sept 2025
ABx Group reports strong heavy rare earth extraction results from larger-scale tests at its Deep Leads project, reinforcing the potential for low-cost, environmentally friendly production. ANSTO remains on track to deliver a mixed rare earth carbonate sample by Q4 2025.
Maxwell Dee
Maxwell Dee
17 Sept 2025